Capital World Investors’s Cano Health, Inc. CANO Stock Holding History

Capital World Investors’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-29,899	Closed	-$17.1M	–	599
2022 Q1	$17.1M	Sell	29,899 -66,069	-69%	-$41.7M	﹤0.01%	501
2021 Q4	$85.5M	Buy	95,968 +10,495	+12%	+$11M	0.01%	385
2021 Q3	$108M	Buy	85,473 +38	+0%	+$46.1K	0.02%	367
2021 Q2	$93.1M	Buy	+85,435	New	+$115M	0.02%	389

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital World Investors's CANO Position: Q2 2022 in Review

Capital World Investors sold out of Cano Health, Inc. (CANO) in Q2 2022, closing a stake of 29,899 shares — an estimated $17.1M sold.

Capital World Investors first reported a position in CANO in Q2 2021 and held it in 4 quarters. The position peaked at $108M in Q3 2021. 145 funds tracked by Wall St. Rank hold CANO as of Q2 2022.

Capital World Investors reported no remaining Cano Health, Inc. position as of Q2 2022 after selling out during the quarter.
Capital World Investors sold 29,899 Cano Health, Inc. shares in Q2 2022, an estimated $17.1M.
Capital World Investors first reported a position in Cano Health, Inc. in Q2 2021 and held it in 4 quarters.
Capital World Investors's Cano Health, Inc. position peaked at $108M in Q3 2021.
145 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q2 2022.

Based on Capital World Investors's 13F filing for Q2 2022, filed 15 Aug 2022.